<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20210908052409N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-01-24</date_registration>
      <primary_sponsor>Shahid Beheshti University of Medical Sciences</primary_sponsor>
      <public_title>Comparison of the Effectiveness of Benzocaine gel and Lidocaine- Prilocaine cream on Pain and Anxiety Reduction due to Dental Injection in Primary Teeth</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the Effectiveness of Benzocaine gel and Lidocaine- Prilocaine cream on Pain and Anxiety Reduction due to Dental Infiltration Anesthesia in Primary Upper Teeth</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-09-25</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>21</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/59599</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Not randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Crossover, Purpose: Treatment, Blinding description: Participant is not aware of the type of topical anesthesia before dental injection. Also , a dental assistant as an outcome adjudicator doesn't know about the type of experimental agent .</study_design>
      <phase>3</phase>
      <hc_freetext>Pain and anxiety due to anesthesia infiltration injection in pediatric dentistry.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Intervention group: In this group , in the first session of treatment after drying the mucosa, 0.5 g of lidocaine-5% surface anesthetic will be applied for 3 minutes and in the second session 0.5 g of benzocaine surface anesthesia gel will be applied for 30 seconds. The child has upright position with headsupport and he/she is not aware of the type of topical anesthesia agents. After application of topical anesthesia, infiltration injection is performed. In both sessions, before using topical anesthesia, during the injection, and finally after the injection, the child's heart rate is measured by the pulse oximeter and the reactions during the injection is recorded by the CPS Scale.Wong Baker Facial Pain Scale is used for recording the pain due to injection. The outcome adjudicator is not aware of the type of experimental agent . Intervention 2: Intervention group: Intervention group: In this group , in the first session of treatment after drying the mucosa, 0.5 g of benzocaine surface anesthesia gel will be applied for 30 seconds and in the second session 0.5 g of lidocaine-5% surface anesthetic will be applied for 3 minutes. The child has upright position with headsupport and he/she is not aware of the type of topical anesthesia agents. After application of topical anesthesia, infiltration injection is performed. Same as the previos group, in both sessions, before using topical anesthesia, during the injection, and finally after the injection, the child's heart rate is measured by the pulse oximeter and the reactions during the injection is recorded by the CPS Scale.Wong Baker Facial Pain Scale is used for recording the pain due to injection. The outcome adjudicator is not aware of the type of experimental agent .</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
The recorded data can be shared based on the studied indicators after identifying the sample individuals, These data include the numbers and scores reported from the Wong Baker FACES Pain Rating Scale, Houpt Scale, and numbers recorded from the finger pulse oximeter at specified times, as well as the results of statistical analysis of these data.

When:
e.g., starting 6 months after publication

To whom:
Researchers working in academic and scientific institutes can apply for access to the data.

Conditions:
Performing statistical analyzes to compare data with other studies in this field is one of the conditions for access to data, so the analysis must be appropriate to the type of data received from the applicant.

Where to obtain:
Applicants can obtain access to the data by submitting a request to the following emails in due time. Moderator: Bardia Hasani Email address: bardia.hasani@gmail.com WhatsApp number: +989012879632

How to obtain:
After submitting the request by email and also sending the request to WhatsApp of the specified person, the applicant will be able to access the information within one week after submitting the request, if she has the requisite conditions.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Kiana Poorzandpoush</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Dentistry, Shahid Beheshti University of Medical Sciences, Daneshjoo Blvd., Daneshgah (Shahriari) Square, Evin, Shahid Chamran Highway</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1983963113</zip>
        <telephone>+98 21 2242 4428</telephone>
        <email>Kianapoorzand@sbmu.ac.ir</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Ali asghar soleimani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Dentistry, Shahid Beheshti University of Medical Sciences, Daneshjoo Blvd., Daneshgah (Shahriari) Square, Evin, Shahid Chamran Highway</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1983969411</zip>
        <telephone>+98 21 2211 2187</telephone>
        <email>drsoleymaniali@yahoo.com</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>4-9 years old children
Children without systemic diseases
Children without history of previous dental treatment Requiring two symmetric posterior primary upper teeth infiltration injection</inclusion_criteria>
      <agemin>4 years</agemin>
      <agemax>9 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Intervention group: In this group , in the first session of treatment after drying the mucosa, 0.5 g of lidocaine-5% surface anesthetic will be applied for 3 minutes and in the second session 0.5 g of benzocaine surface anesthesia gel will be applied for 30 seconds. The child has upright position with headsupport and he/she is not aware of the type of topical anesthesia agents. After application of topical anesthesia, infiltration injection is performed. In both sessions, before using topical anesthesia, during the injection, and finally after the injection, the child's heart rate is measured by the pulse oximeter and the reactions during the injection is recorded by the CPS Scale.Wong Baker Facial Pain Scale is used for recording the pain due to injection. The outcome adjudicator is not aware of the type of experimental agent .</i_keyword>
      <i_keyword>Intervention group: Intervention group: In this group , in the first session of treatment after drying the mucosa, 0.5 g of benzocaine surface anesthesia gel will be applied for 30 seconds and in the second session 0.5 g of lidocaine-5% surface anesthetic will be applied for 3 minutes. The child has upright position with headsupport and he/she is not aware of the type of topical anesthesia agents. After application of topical anesthesia, infiltration injection is performed. Same as the previos group, in both sessions, before using topical anesthesia, during the injection, and finally after the injection, the child's heart rate is measured by the pulse oximeter and the reactions during the injection is recorded by the CPS Scale.Wong Baker Facial Pain Scale is used for recording the pain due to injection. The outcome adjudicator is not aware of the type of experimental agent .</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The perceived pain degree using Wong Baker Faces Pain scale(wbfps), the assessed pain and anxiety using children’s Hospital of Eastern Ontario Pain Scale (CPS), heart rate ratio using pulse oximeter. Timepoint: Recording the degree of perceived pain after injection using Wong Baker Facial Pain Scale(wbfps) . Pain and anxiety assessment using CPS Scale during injection. Assessment of heart rate before, during and after injection using pulse oximeter device . Method of measurement: Recording the degree of perceived pain after injection using Wong Baker Facial Pain Scale . Pain and anxiety assessment using CPS Scale during injection. Assessment of heart rate before, during and after injection using pulse oximeter device .</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shahid Beheshti University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-08-25</approval_date>
        <contact_name>Ethics committee of Shahid Beheshti University of Medical Sciences</contact_name>
        <contact_address>School of Dentistry, Shahid Beheshti University of Medical Sciences, Daneshjoo Blvd., Daneshgah (Shahriari) Square, Evin, Shahid Chamran Highway Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
